Stephavanine - ≥95% , CAS No.33116-33-5

CAS: 33116-33-5 Cat. No.: S955434 PubChem CID: 421509
AVAILABLE TO ORDER
GRADE & PURITY ≥95%
Storage
Room temperature
★
Size
Germany (EU)
USA*
Price
Qty
5mg
S955434-5mg
Made to order · 8–12 wks
€1,000.42
Enter a quantity for the sizes you want to add.

Specifications

Specifications & Purity
≥95%
Storage
Room temperature
Purity
≥95%
Names and Identifiers
SMILES
COC1=C(C=CC(=C1)C(=O)OC2CC34CCNC35CC(C6=CC7=C(C=C46)OCO7)OC5(C2O)OC)O
IUPAC Name
(15-hydroxy-14-methoxy-5,7,21-trioxa-20-azahexacyclo[11.4.3.111,14.01,13.02,10.04,8]henicosa-2,4(8),9-trien-16-yl) 4-hydroxy-3-methoxybenzoate
InChIKey
BTDVYOKUHWMJJD-UHFFFAOYSA-N
InChI
1S/C26H27NO9/c1-31-17-7-13(3-4-16(17)28)23(30)35-21-10-24-5-6-27-25(24)11-20(36-26(25,32-2)22(21)29)14-8-18-19(9-15(14)24)34-12-33-18/h3-4,7-9,20-22,27-29H,5-6,10-12H2,1-2H3
Isomeric SMILES
COC1=C(C=CC(=C1)C(=O)OC2CC34CCNC35CC(C6=CC7=C(C=C46)OCO7)OC5(C2O)OC)O
Alternate CAS
33116-33-5
PubChem CID
421509
NSC Number
135026

Advanced Data

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassAlkaloids and derivatives
ClassHasubanan alkaloids
SubclassNot available
Intermediate Tree Nodes Not available
Direct ParentHasubanan alkaloids
Alternative Parents Phenanthrenes and derivatives  M-methoxybenzoic acids and derivatives  p-Hydroxybenzoic acid alkyl esters  Tetralins  Methoxyphenols  Benzodioxoles  Indolines  Phenoxy compounds  Anisoles  Methoxybenzenes  Benzoyl derivatives  Alkyl aryl ethers  1-hydroxy-2-unsubstituted benzenoids  Ketals  Aralkylamines  Pyrrolidines  Tetrahydrofurans  Amino acids and derivatives  Secondary alcohols  Cyclic alcohols and derivatives  Carboxylic acid esters  Oxacyclic compounds  Monocarboxylic acids and derivatives  Azacyclic compounds  Dialkylamines  Hydrocarbon derivatives  Organic oxides  Organopnictogen compounds  
Molecular FrameworkAromatic heteropolycyclic compounds
Substituents Hasubanan skeleton - Phenanthrene - M-methoxybenzoic acid or derivatives - P-hydroxybenzoic acid alkyl ester - P-hydroxybenzoic acid ester - Methoxyphenol - Tetralin - Benzoate ester - Dihydroindole - Indole or derivatives - Benzodioxole - Benzoic acid or derivatives - Phenoxy compound - Anisole - Phenol ether - Benzoyl - Methoxybenzene - Phenol - 1-hydroxy-2-unsubstituted benzenoid - Ketal - Aralkylamine - Alkyl aryl ether - Monocyclic benzene moiety - Benzenoid - Tetrahydrofuran - Pyrrolidine - Cyclic alcohol - Carboxylic acid ester - Secondary alcohol - Amino acid or derivatives - Acetal - Oxacycle - Azacycle - Organoheterocyclic compound - Carboxylic acid derivative - Secondary amine - Secondary aliphatic amine - Ether - Monocarboxylic acid or derivatives - Alcohol - Organic nitrogen compound - Amine - Organic oxygen compound - Organopnictogen compound - Organooxygen compound - Organic oxide - Organonitrogen compound - Hydrocarbon derivative - Aromatic heteropolycyclic compound
DescriptionThis compound belongs to the class of organic compounds known as hasubanan alkaloids. These are alkaloids with a structure based on the hasubanan skeleton, a tetracyclic propellane.
External Descriptors Not available
3D Structure
Interactive Chemical Structure Model





Certificates (CoA,COO,BSE/TSE and Analysis Chart)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Chemical and Physical Properties
Molecular Weight497.5
XLogP31.600
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count10
Rotatable Bond Count5
Exact Mass497.169 Da
Monoisotopic Mass497.169 Da
Topological Polar Surface Area125.000 Ų
Heavy Atom Count36
Formal Charge0
Complexity905.000
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count6
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds0
Covalently-Bonded Unit Count1
Solution Calculators
Reviews

Customer Reviews

Application Protocols

No tested application protocols are provided for this item.

General small-molecule handling in screening workflows (non-item-specific):

  • Stock preparation: Dissolve in DMSO at 10–50 mM. Verify complete dissolution (visual and LC). Store as small aliquots to avoid freeze–thaw.
  • Working solutions: Dilute into assay buffer/media maintaining consistent vehicle content across controls and treatments. Monitor for precipitation and adsorptive losses (precondition plasticware if needed).
  • Analytical: For LC-MS quantitation, prepare calibration curves in matched matrices and include internal standards. Evaluate short-term stability on autosampler.

Please adapt these general steps to your specific assay platform and consult the compound’s CoA/SDS before use.

Biological Roles

Item-specific biological roles and mechanisms of action are not provided in the current listing.

General guidance for researchers (non-item-specific):

  • If using this compound as a probe or screening hit, consult peer-reviewed literature indexed by the CAS (33116-33-5) or CID (421509) to identify any reported biological targets, assay systems, or phenotypes. Confirm concordance of structure and stereochemistry before extrapolating literature results.
  • Establish baseline properties relevant to biological studies (solubility in assay media, chemical stability, redox/light sensitivity, potential for non-specific aggregation). Employ counterscreens (e.g., detergent-sensitive aggregation assays, redox interference controls) to reduce assay artifacts.
  • For cell-based work, characterize stock cytotoxicity and vehicle effects across intended concentration ranges. If ionizable, assess pH-dependent permeability and potential lysosomotropic behavior.
  • Document and control batch-to-batch variability via identity and purity verification (LC-MS/NMR) prior to biological testing.

No clinical or therapeutic claims are made for this product. It is supplied strictly for research use only.

Buffer Applications

This product is a small organic compound and is not a buffering agent. No canonical buffering systems or recipes apply.

Practical notes (general):

  • If dosing into aqueous buffers for assays, prepare concentrated stocks in a miscible organic solvent (commonly DMSO), then dilute into buffer while monitoring for precipitation. Maintain a consistent final co-solvent percentage between control and treated samples.
  • Filter clarify working solutions if compatible with your assay (e.g., 0.22 µm PTFE or PVDF) to remove particulates.
  • Record the exact buffer composition, pH, and co-solvent fraction used for reproducibility.
Green Alternatives

This item is a listed small molecule, not a process solvent or bulk reagent; therefore, direct substitution by a “green alternative” is generally not applicable.

Sustainability considerations surrounding its use (general, non-item-specific):

  • Prefer greener dissolution media where compatible with your application: water-based buffers with minimal DMSO or bio-based solvents (e.g., Cyrene, 2-MeTHF) for preparative work, provided the compound is sufficiently soluble and stable.
  • When preparing analytical samples, opt for ACN or MeOH over more hazardous chlorinated solvents, if chromatographic performance allows.
  • Minimize solvent volumes in stock preparation and storage by using concentrated aliquots and microvolume handling to reduce waste.
  • Implement closed-vial handling and microscale assays to limit exposure and environmental release.

End-of-life and waste:

  • Collect any solutions and rinse solvents for disposal according to local regulations and institutional environmental health and safety policies. Avoid drain disposal.

If you plan synthetic modifications using this scaffold, consider green reaction media and energy-efficient techniques (e.g., aqueous micellar catalysis, solvent minimization, flow chemistry) where compatible with its functional groups once known.

Pharmaceutical Uses

No pharmacopeial status, excipient role, or formulation use is provided for this item. It is supplied for research use only and is not intended for human or veterinary use.

General considerations for formulation research (non-item-specific):

  • If exploring preformulation properties, determine solubility across pH 2–8, intrinsic dissolution rate, and chemical stability (oxidative, hydrolytic, photolytic). Assess salt formation potential if ionizable.
  • For in vitro studies, standard practice is to dose from DMSO stocks and limit final vehicle content to minimize confounding effects.
  • Any advanced formulation efforts (e.g., nanosuspensions, cyclodextrin complexes, lipid-based systems) should be preceded by a full physicochemical profile and stability assessment. These activities remain within research scope only.
Physical Properties

Item-specific physicochemical data are not included in the current product record.

  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Melting point: Not specified for this item; refer to CoA/Spec Sheet.
  • Boiling point: Not specified for this item; refer to CoA/Spec Sheet.
  • Density: Not specified for this item; refer to CoA/Spec Sheet.
  • Refractive index: Not specified for this item; refer to CoA/Spec Sheet.
  • pKa(s): Not specified for this item; refer to CoA/Spec Sheet.
  • logP/logD: Not specified for this item; refer to CoA/Spec Sheet.
  • Aqueous/organic solubility: Not specified for this item; refer to CoA/Spec Sheet.

General practical guidance (non-item-specific):

  • For unknown solids in screening libraries, initial dissolution trials typically use DMSO (analytical or anhydrous grade) at 10–50 mM, followed by serial dilution into assay media or buffer with co-solvent fractions kept ≤1% v/v when possible.
  • If the compound is poorly soluble in DMSO, stepwise testing in MeOH, ACN, DMF, and EtOH can help define a working solvent system. Apply gentle heating (≤40 °C) and vortex/sonication as needed.
  • If the compound contains basic nitrogens (common in many alkaloids), modest solubility improvements may be achieved by forming salts in situ (e.g., with HCl or TFA) for analytical sample prep; verify compatibility with your method.
Quality & Grades
  • Grade/Purity: Not specified for this item; refer to CoA/Spec Sheet.
  • Stabilizers/Inhibitors: Not specified for this item; refer to CoA/Spec Sheet.

Interpretation and practical notes (general):

  • If supplied as a screening compound, purity is commonly ≥95% by HPLC/UPLC unless otherwise stated; however, you must confirm the exact purity, analytical method (UV/ELSD/MS), and water/solvent content on the item’s CoA.
  • Chromatographic grade statements (e.g., HPLC grade) refer to solvents, not typical for solid small molecules. For small molecules, key quality metrics include: assay purity, single major component by LC-MS, residual solvents, counterion content (for salts), and identity confirmation (NMR/HRMS).
  • If the item is a natural product isolate or semisynthetic derivative, batch-to-batch variations in minor impurities may occur; review the batch CoA and request supplementary spectra (1H/13C NMR, LC-MS, HPLC traces) if needed for regulated workflows.
  • If the compound is amorphous vs. crystalline, polymorphism can influence dissolution; check the CoA for physical form and any noted polymorph.

For method development and bioassays, we recommend verifying identity and purity of the received lot with an orthogonal technique (e.g., LC-MS plus 1H NMR).

Reaction & Applications

This product is listed under a small-molecule/compound library category; no manufacturer application notes are provided for synthetic transformations.

General research uses (non-item-specific):

  • Suitable for use as a screening library member in biochemical or cell-based assays, target deconvolution studies, and SAR exploration when combined with analogs.
  • Can serve as a reference standard for analytical method development (e.g., LC-MS retention time locking, fragmentation library creation) once structure and purity are confirmed.

If the compound is intended for synthetic use (derivatization or as a scaffold):

  • Without structural information, specific reaction classes (e.g., N-alkylation, acylation, cross-coupling) cannot be recommended. Obtain the verified structure (SMILES/SDF) and assess functional group compatibility with your planned transformation.
  • Prior to any scale-up or derivatization, characterize the material (1H/13C NMR, LC-MS, HPLC purity, water content) to ensure reproducibility and to understand impurity profiles that may interfere with downstream chemistry.

For bioassay deployment, confirm stability in assay buffers, light exposure, and at working concentrations over the assay timeframe (preliminary stability indicating LC recommended).

Reaction Conditions

No item-specific reaction conditions are provided, and without a verified structure it is not appropriate to suggest specific reagents, catalysts, or temperature profiles.

General method development guidance (non-item-specific):

  • Begin with microscale reactions (≤0.05 mmol) to probe stability and reactivity under acidic/basic, oxidative/reductive, and thermal conditions.
  • Select solvents guided by polarity needs and safety: for polar substrates consider MeCN, MeOH, or DMAc; for less polar, consider toluene, 2-MeTHF, or CPME. Favor greener options where feasible.
  • Employ thin-layer chromatography (TLC) and LC-MS for rapid monitoring. Build a short stability panel (e.g., 40–60 °C, air vs. inert atmosphere, light vs. dark) to inform scale-up.
  • If the compound contains basic nitrogens (common in many small molecules), account for salt formation and potential solubility shifts when choosing workup and purification conditions.

Report and document all conditions and outcomes, as batch variability and unknown functional groups can strongly influence reaction performance.

Safety & Handling

Hazard classification is not provided in the current listing. Treat as a research chemical of unknown hazard profile.

  • Signal word: Not specified for this item; refer to SDS.
  • GHS classification and H-statements: Not specified for this item; refer to SDS.
  • Pictograms: Not specified for this item; refer to SDS.

General laboratory precautions (non-item-specific):

  • Use in a chemical fume hood. Wear appropriate PPE: lab coat, safety glasses, and suitable chemically resistant gloves (e.g., nitrile). Avoid inhalation, ingestion, and skin/eye contact.
  • Storage incompatibilities should be assessed once functional groups are known; in absence of data, segregate from strong oxidizers/acids/bases and store in a tightly closed, labeled container.
  • First aid (general): In case of skin contact, wash with soap and water. For eye contact, rinse cautiously with water for several minutes; remove contact lenses if present and easy to do. If inhaled, move to fresh air. If swallowed, rinse mouth. Seek medical attention for any persistent symptoms.
  • Spill/accidental release: Contain and collect with inert absorbent. Avoid dust formation. Dispose of according to institutional and local regulations.

Always consult the product’s SDS for authoritative safety information prior to use.

Solvent Selection

Item-specific solubility data are not provided.

General strategy for small-molecule dissolution (non-item-specific):

  • Primary solvent: DMSO is the standard for preparing concentrated stock solutions (e.g., 10–50 mM). Verify clarity after mixing; gentle warming (≤40 °C) and sonication can assist.
  • Secondary solvents: If DMSO is unsuitable, test MeOH, ACN, EtOH, and DMF. For strongly lipophilic compounds, consider co-solvent blends with isopropanol or small fractions of PEG-400.
  • Aqueous use: For biological assays, dilute DMSO stocks into buffer/media keeping final DMSO ≤0.1–1% v/v, as assay permits. Surfactants (e.g., 0.01–0.05% Tween 80) can mitigate precipitation in some assay formats.
  • pH adjustment: If the compound has ionizable groups (e.g., basic amines), modest pH adjustment or salt formation can improve aqueous handling for analytical injections.

Quick comparison (general):

  • DMSO: maximal solvation power; universally used in screening libraries.
  • MeOH/ACN: LC-compatible, lower viscosity; may reduce matrix effects in LC-MS sample prep.
  • DMF: strong solvating power but higher boiling point and more stringent handling.

Because structure-specific polarity and ionization are not provided, confirm solvent choice empirically and document stability of working solutions under your assay/storage conditions.

Storage & Reconstitution

Storage conditions: Room temperature (as provided in product data). Avoid excessive heat, moisture, and light. Store in a tightly closed container.

  • Shipped in: Not specified for this item; refer to CoA/Spec Sheet.
  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.

General reconstitution guidance (non-item-specific):

  • Prepare concentrated stocks in dry DMSO (typ. 10–50 mM) unless otherwise required by your application. If aqueous use is needed, dilute the DMSO stock into buffer immediately before use to minimize precipitation.
  • Filtration: If particulate matter is observed, clarify through 0.22 µm PTFE/PVDF. Avoid cellulose esters if strong organic solvents are used.
  • Aliquoting: Divide into single-use aliquots to prevent repeated freeze–thaw and headspace moisture uptake. While room-temperature storage is indicated for the solid, frozen storage (e.g., −20 °C) of DMSO stocks is generally advisable; allow to equilibrate to room temperature before opening to limit moisture condensation.
  • Stability: Item-specific stability (thermal, photolytic, hydrolytic) is not provided; confirm by periodic LC-MS/HPLC checks of stored stocks.

Always consult the CoA and SDS for definitive storage, stability, and handling instructions.

Structure & Identity

Stephavanine (SKU: S955434) is listed in our small-molecule/compound library category. Limited structural metadata are available in the current product record.

  • CAS: 33116-33-5
  • CID: 421509 (literature/registry reference; verify against current databases)
  • InChIKey: 33651 (as provided; unusual format—verify on CoA/SDS)
  • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.

Structural features (general guidance):

  • Item-specific functional groups, ring systems, stereochemistry, and 2D topology are not provided in the current listing. If you require definitive atom connectivity (e.g., for registration, docking, or analytical method development), request the detailed CoA/structure file (SMILES/SDF) from customer support or consult a trusted chemical registry using the CAS number.

2D structure description (general):

  • Without a provided SMILES or structure file, a text description of the 2D scaffold cannot be given. For cheminformatics workflows (property prediction, substructure search, PAINS filtering), please retrieve a verified structure (SDF/MOL) tied to the CAS listed above.
Synthetic Utility

Specific synthetic utility cannot be detailed without a verified structure and functional group inventory.

General scaffold-oriented guidance (non-item-specific):

  • If the compound is to serve as a lead for analogue synthesis, obtain a confirmed structural file (SDF/MOL) and map potential diversification vectors (e.g., positions amenable to electrophilic/nucleophilic substitution, N-alkylation/acylation sites, or cross-coupling handles if aryl halides are present).
  • Conduct reactivity scouting on milligram scale to determine stability toward acids/bases, oxidants/reductants, and common coupling conditions. Establish protecting group strategy if multiple nucleophilic/heteroatom sites exist.
  • Analytical control: Develop an LC or UPLC method capable of resolving starting material, expected regioisomers, and plausible impurities; include MS detection to rapidly triage reactions.

Once functional groups are known, a tailored set of transformations (e.g., amide coupling, reductive amination, Buchwald–Hartwig, Suzuki–Miyaura, late-stage C–H functionalization) can be planned around the scaffold’s reactivity profile.

Target Specificity

Not applicable. This item is not an antibody, enzyme, or biologic with defined binding targets in our catalog entry, and no validated molecular target information is provided for this small molecule.

If using the compound as a probe in biology (general guidance):

  • Establish target engagement using orthogonal assays (biophysical and cellular) and confirm structure-activity relationships with close analogs.
  • Include selectivity panels where possible to detect off-target interactions.

No target specificity claims are made for this product.

Frequently Asked Questions

What is the purity of this product?
This product is supplied at ≥95% purity (chemical assay). Lot-specific values are stated on the Certificate of Analysis.
How should this product be stored?
Store at room temperature.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is 33116-33-5. InChIKey BTDVYOKUHWMJJD-UHFFFAOYSA-N.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.